Denmark· DK-28106430220

Andatin

A imipenem and cilastatin product containing cilastatinnatrium, imipenemmonohydrat, registered in Denmark by Macure Pharma ApS. The same ATC class is registered in 12 of our 19 countries.

ATC J01DH51

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedAndatinATCJ01DH51REGISTER NO.DK-28106430220PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Imipenem and cilastatin is registered in 12 of 19 countries.

Countries holding a registration under ATC J01DH51 (imipenem and cilastatin), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 7 of them publish a price we can compare per daily dose

Imipenem and cilastatin · ATC J01DH51

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Cilastatinnatrium, Imipenemmonohydrat
Manufacturer
Macure Pharma ApS
Country
Denmark (DK)
ATC code
J01DH51
ATC class
Imipenem and cilastatin
Defined daily dose
2 g, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106430220

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for imipenem and cilastatin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Imipenem and cilastatin · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3520492-30b1-4182-af5c-6497270bb895
GET /v1/drugs/f3520492-30b1-4182-af5c-6497270bb895?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "pulver til infusionsvæske, opløsning",
  "source": "dkma",
  "strength": "500+500 mg",
  "auth_role": "CMS",
  "dk_drugid": "28106430220",
  "substance": "Cilastatinnatrium, Imipenemmonohydrat",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "44280"
}

See everything about imipenem and cilastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.